Paul specialises in the commercialisation of innovative technology and the impact of technological developments on businesses and society. Matt joined Evonetix in 2019, as Head of Mechanical Engineering, after spending 12 years at Cambridge Consultants. Jason was raised in Berkeley and on a farm on the North Coast of California, where his family raised game birds for restaurants in the Bay Area. The company aims to introduce a biochemical process for DNA and RNA synthesis based on the use of efficient enzymes. He has also held board positions at Psynova Neurotech, Bioscale and Enigma Diagnostics. Evonetix Raises $24M in Extended Series B Funding Round Raquel Sanches-Kuiper was appointed Director of Biology of Evonetix in February 2017. For more than 50 years, Cambridge Consultants has led the way in innovative product development and not only been the development partner of choice to many of the worlds leading blue chips, but has also founded an array of ambitious start-up companies. Amount. 9a Coldhams Business Park, Norman Way In addition to publishing nearly 600 peer-reviewed scientific papers, he is the author of several books that address scientific issues in the context of a broader humanist debate. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Trevor was also responsible for the Industrialisation of new developments including Characterisation, Qualification and Production Test. Iridia is developing a DNA-based data storage solution. Get the full list, Youre viewing 5 of 10 board members. Michael holds a PhD in Molecular Genetics and Protein Biochemistry from the Department of Biochemistry and Genetics at the University of Newcastle and has also completed numerous professional qualifications and training in marketing, management, and IP law. Previously, Vishal worked at Atlas Venture, The Wellcome Trust and Radiant Capital. The company is committed to providing a solution that will be used in line with Current Good Manufacturing Practice (CGMP) as outlined by the FDA. The funds will be used by Zaptic to continue its growth, expand into new markets and new verticals. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. Find out more about the individuals that . cale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. He joined Cambridge Consultants in 2001, and was responsible for the leadership of many of their largest and most technically challenging projects. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. 1 Beauty Stock to Help Give Your Porftolio a Makeover Vegas operations grew revenue 27%. The official website of Evonetix is evonetix.com He was previously Chief Operations Officer at GreenPeak technologies B.V. (Qorvo Inc.) responsible for the mass production of Zigbee and Bluetooth devices servicing the TV/Set-top-box and IoT markets. Evonetix is a growing biotechnology company which is set to revolutionisegene synthesis as needed to facilitate the View all To add symbols: Type a symbol or company name. He holds a PhD and MEng in Electronic Engineering, both from Loughborough University. He has experience working in a broad range of roles in start-ups, large corporations, government and consultancy. September 09, 2020 08:00 AM Eastern Daylight Time. For specific trademark information, see www.evonetix.com/legal, Today is National #DNA Day! Jason Pontin is a Partner at DCVC, where his belief that emerging technologies and new scientific insights can solve urgent challenges and expand human possibilities inspires his investments in Deep Tech and life sciences companies. Get the full list, Morningstar Institutional Equity Research, Reaction duration control for reaction performed on biomolecule samples, Accessing data storage provided using double-stranded nucleic acid molecules, Co-Founder, Chief Technology Officer & Board Member. His interests include understanding the influence of new technologies and how society views their potential impact on human flourishing. our sites and services. With this round, the total investment raised by Zaptic accounts for $16 million. All trademarks are the property of Evonetix Ltd. or their respective owners. EVONETIX LTD ('Evonetix'), the synthetic biology company bringing semiconductor . Combined with the Companys patented chemistry, this approach enables the accurate synthesis of thousands of sequences on a single chip to meet the demand for complex libraries and assembly of long DNA, addressing the DNA supply bottleneck in the field of synthetic biology. affect the user interaction and engagement with the company. The platform has the potential to revolutionise the way this DNA is prepared and delivered to users in the rapidly growing field of synthetic biology, accelerating research in applications across pharma, biotech, food, agriculture, and data storage. The investment round was led by London VC Molten Ventures that recently backed Evonetix and Hadean , with participation from existing investors. Evonetix Ltd operates as biotechnology company. Evonetix headquarters are at CAMBRIDGE, England, February 07, 2023--EVONETIX LTD ('Evonetix'), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 . Malcolm is a Fellow Chartered Accountant (FCA) of the Institute of Chartered Accountants in England and Wales and has an MA in Geography from the University of Cambridge. His research focuses on developing quantitative biophysical methods, applied to biology and biomedicine. Written by Keith Noonan and Jeremy Bowman for The Motley Fool ->. . This approach enables the accurate synthesis of thousands of sequences on a single chip to meet the demand for complex libraries and assembly of long DNA in days rather than weeks, accelerating research across the exciting field of synthetic biology. She then moved to leadership roles of global multidisciplinary projects to support product development and introduction of new products. Malcolm was previously Group Finance Director at Cambridge Cognition, an AIM listed public company specialising in brain health, for six years. Helixworks Technologies is a biotechnology company specializing in DNA synthesis. and determine its next move. Researchers are invited to apply to be included in the Companys early access program to receive some of the first DNA prepared using its technology and demonstrate the efficacy of Evonetix DNA in routine molecular biology workflows. March 2, 2020. Before these roles, Malcolm had over 15 years experience in professional services with PwC. The Company will then look to scale up the parallel synthesis capacity of its semiconductor chips as it works toward future full commercialisation of its technology. Evonetix is ready to meet these challenges and open the door to the exciting next phase of our development., To apply to be included in the early access program, please visit: www.evonetix.com/access, View source version on businesswire.com: https://www.businesswire.com/news/home/20220816005493/en/, Lorna Cuddon The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. BioCentury - Feb. 7 Quick Takes: Garuda advancing stem cell program Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Evonetix brings together the talents of an astonishing group of scientists and engineers, across biology, physics, electronics, chemistry, software and mechanics; all with the same mission, to unlock the capabilities of semiconductor technology for the world of synthetic biology. Funding will enable development of DNA synthesis chip technology to commercial scale. Evonetix is a Cambridge . Evonetix Stock Price, Funding, Valuation, Revenue & Financial Statements Malcolm joined Evonetix in June 2021 with over 20 years of experience. Jason Pontin is a Partner at DCVC, where his belief that emerging technologies and new scientific insights can solve urgent challenges and expand human possibilities inspires his investments in Deep Tech and life sciences companies. At TED 2013, he delivered a Talk, Can technology solve our big problems? which has been seen 1.6 million times. PDF IDFCFIRSTBANK/SD/29/2023-24 April 29, 2023 National Stock Exchange of Prior to joining Evonetix he was Senior Vice President and Chief Commercial Officer at Fluidigm Corp, where he was responsible for leading all commercial activities, driving revenue growth, and expanding the Companys global reach. Stock Market | Finance information on technology stack, industry listing, and other details. Equity securities are offered through EquityZen Securities. Signet Jewelers doesn't get much attention on Wall Street, but the jewelry stock has crushed the market over the last three years. Vishal is a qualified physician and chairman of the Digital Health Forum. This profile is based on publicly available information and is intended to be informative in nature. This fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round. Cambridge Consultants invested in Evonetix's Series B - II funding round. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Helixworks Technologies is a biotechnology company specializing in DNA synthesis. Check the background of this firm on FINRAs BrokerCheck. Malcolm joined Evonetix in June 2021 with over 20 years of experience. Request an Annual Quote. Evonetix is included in 4 Expert Collections, including Agriculture Technology (Agtech). Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs). and M.A in humanities fields completely unrelated to his investment interests. Copy and paste multiple symbols separated by . In 2012, he became a Fellow of the Royal Society in recognition of his contribution to the translation of science into business, in 2013 a Distinguished Fellow of BCS, the Chartered Institute for IT, and in 2015 an Honorary Knight Commander (KBE) for services to engineering and industry. Dr. Vishal Gulati is one of the Europes leading digital healthcare investors. 3 Reasons I'm Bullish on MGM Resorts Stock | The Motley Fool Here's why I'm bullish on this casino stock. We are a Cambridge-based company developing a radically different approach to gene synthesis. As well as leading on financial and related matters, Malcolm was the lead business partner to the sales and marketing, operations, and R&D functions. He was educated in the United Kingdom at Keble College, Oxford University, where he was awarded a B.A. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. EquityZen Securities LLC (EquityZen Securities) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm. In a highly competitive market, manufacturers need to enable their workforce to flex across new equipment, processes, and products, with a heavy focus on the alignment of people and data. and which sectors. Claim your profile to get in front of buyers, investors, and analysts. Matt Hill is the VP of Research and Development at Evonetix, with overall responsibility for the 100-strong team of technologists; spanning engineering, digital and cloud, and science. Workers need on-the-job assistance in knowing what to do, when to do it, and how best to do it at the point of use. 9a Coldhams Business Park, Norman Way Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. It not only unlocks measurable improvements in productivity, quality and safety but also enables a smooth transfer of knowledge between the retiring and new generation of workers to improve market resiliency. He trained and qualified, in 1986, as a Chartered Accountant with Ernst & Young in London, UK. The investment will fuel the development of Evonetix's semiconductor technology which enables accurate synthesis of thousands of sequences on a single chip andassembly of gene-length DNA in days rather than weeks. Providence Investment Company is the family office of Hermann Hauser and, together with Cambridge Consultants, is the founding investor of Evonetix. Explore frequently asked questions about Evonetixs business, including founding details, header quarters, Get their email address, phone numbers, and other details from Linkedin or any website. Date.